Hidetaka Yamamoto

16PUBLICATIONS
47CO-AUTHORS
Predictive and prognostic markersDisease surveillanceCancer therapy (excl. chemotherapy and radiation therapy)Medical biotechnology diagnostics (incl. biosensors)Cancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Dec 22, 2025
Claudin-18 expression in gastric type adenocarcinoma and HPV-associated adenocarcinoma of the uterine cervix.

Nobuko Yasutake, Yuki Yokawa, Takehiro Tanaka

|Feb 17, 2025
Kikuchi-Fujimoto disease: investigating comprehensive clinicopathological features and risk factors for recurrence.

Midori Filiz Nishimura, Chikako Sakao, Yuka Kurokawa

|Jan 13, 2025
Myeloid Cells Induce Infiltration and Activation of B Cells and CD4+ T Follicular Helper Cells to Sensitize Brain Metastases to Combination Immunotherapy.

Toshifumi Ninomiya, Naoya Kemmotsu, Fumiaki Mukohara

|Jul 29, 2024
Reappraisal of bone and soft tissue cytopathology classification using the modified Milan system.

Masaki Naka, Hidetaka Yamamoto, Kenichi Kohashi

|Mar 06, 2024
Immunohistochemical p16 overexpression and Rb loss correlate with high-risk human papillomavirus infection in endocervical adenocarcinomas.

Nobuko Yasutake, Hidetaka Yamamoto, Ryosuke Kuga

|Jun 14, 2022
Nuclear expression of AFF2 C-terminus is a sensitive and specific ancillary marker for DEK::AFF2 carcinoma of the sinonasal tract.

Ying-Ju Kuo, James S Lewis, Tra Truong

Pageof 3

Frequent Collaborators

5 joint publications

Yoshinao Oda

3 joint publications

Hiroshi Inagaki

2 joint publications

Hideaki Yahata

2 joint publications

Kenzo Sonoda